Reaction
Repetitive Speech reporting signals
As of the last recalculation, Repetitive Speech appears in 553 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is RIVASTIGMINE (PRR 32.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rivastigmine | 16 | 32.9 | 32.9 |
| Pseudoephedrine Hydrochloride | 7 | 26.0 | 26.0 |
| Pseudoephedrine Hcl | 7 | 24.2 | 24.2 |
| Cenobamate | 5 | 22.7 | 22.8 |
| Memantine | 8 | 22.3 | 22.3 |
| Memantine Hydrochloride | 8 | 22.3 | 22.3 |
| Atomoxetine Hydrochloride | 13 | 21.0 | 21.0 |
| Avapritinib | 6 | 18.8 | 18.9 |
| Lurasidone Hydrochloride | 7 | 12.7 | 12.7 |
| Pimavanserin Tartrate | 12 | 8.3 | 8.3 |
| Valbenazine | 5 | 7.5 | 7.5 |